BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)

CUSIP: 09061G101

Q1 2024 13F Holders as of 31 Mar 2024

Security identity 2 facts
Shares outstanding
192,632,743
Holder snapshot 9 facts
Share change
+763,479
Put/Call ratio
102%
Reported price per share
$87.34
Number of holders
550
Value change
+$52,133,744
Number of buys
255
Number of sells
252

Security key

09061G101

Report period

Q1 2024

Institutions

550

Top holders

10

Ownership snapshot

Top reported holders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
PRIMECAP MANAGEMENT CO/CA/
13D/G signal
Evidence rows
15
Latest as of
31 Dec 2023
13F Lead comparable stake: 9.6% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
9.6%
$1,775,513,941
18,414,374 shares
31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
9.4%
$1,740,386,979
18,050,062 shares
31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
7.6%
$1,415,604,123
14,681,644 shares
31 Dec 2023
DODGE & COX
13F
Company
13F
7.3%
$1,349,307,554
13,994,063 shares
31 Dec 2023
Capital Research Global Investors
13F
Company
13F
5.6%
$1,038,906,821
10,774,641 shares
31 Dec 2023
STATE STREET CORP
13F
Company
13F
3.5%
$648,956,256
6,730,515 shares
31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
550
Shares
186,676,383
Rows available
550
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q1 2024 vs Q4 2023 Across Filers

Q4 2023 holders
540
Q1 2024 holders
550
Holder diff
10
Investor Q4 2023 Shares Q1 2024 Shares Share Diff Share Chg % Q4 2023 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .